In Vitro Study on the Antimicrobial Activity of Various Antibiotics Against Clinical Isolates Of Streptococcus Pneumoniae From Belgium Collected During Winter 1998-1999

References

• Hansman D, Bullen MM. A resistant pneumococcus. Lancet. 1967; ii: 264–5.
   Google Scholar
• Lonks JR, Medeiros AA. The growing threat of antibiotic-resistant Streptococcus pneumoniae. Med Clin N Amer. 1995; 79: 523–35.
   Google Scholar
• Hermans PWM, Sluijter M, Elzenaar K, et al. Penicillin-resistant Streptococcus pneumoniae in the Netherlands : results of a 1-year molecular epidemiologic survey. J Infect Dis. 1997; 175: 1413–22.
   Google Scholar
• Hakenbeck R. β-Lactam resistant Streptococcus pneumoniae : epidemiology and evolutionary mechanisms. Chemother. 1999; 45: 83–94.
   Google Scholar
• Mason EO, Kaplan SL. Penicillin-resistant pneumococci in the United States. Ped Infect Dis J. 1995; 14: 1017–8.
   Google Scholar
• Yanhoof R, Christiaens F, Dierickx R, Coignau H, Butzler JP. In vitro evaluation of the antibiotic susceptibility of Streptococcus pneumoniae : pneumococci relatively resistant to penicillin in Brussels. Acta Clin Belg. 1980; 35: 343–8.
   Google Scholar
• Verhaegen J, Glupczynski Y, Verbist L, et al. Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980–1993. Clin Infect Dis. 1995; 20: 1339–45.
   Google Scholar
• Vanhoof R, Carpentier M, Glupczynski Y, et al. In vitro susceptibility of 176 clinical isolates of Streptococcus pneumoniae to 11 β-lactams, erythromycin ad tetracycline. Acta Clin Belg. 1996;51:377–85.
   Google Scholar
• Vanhoof R, Carpentier M, Glupczynski Y, et al.. Surveillance of pneumococcal resistance in Belgium during winter 1996–1997. Acta Clin Belg. 1998; 53: 275–81.
   Google Scholar
• Verhaegen J, Vandeven J, Verbiest N, Van Eldere J, Verbist L. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Belgium-update (1994–98). Clin Microbiol Infect. 2000; 6: 308–15.
   Google Scholar
• Ruoff KL. Streptococcus. In Murray PR. Ed. Manual of Clinical Microbiology. Sixth Edition. Washington. D.C. : ASM. 1995: 299–307.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. NCCLS Document M7-A4, vol. 17 No. 2, Villanova, PA, 1997.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. NCCLS Document M100-S10, Vol. 20, No. 2, Wayne PA, 2000.
   Google Scholar
• Baquero F, Garcia-Rodriguez JA, Garcia de Lomas J, Aguilar L, and the Spanish surveillance group for respiratory pathogens. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain : results of a 1-year (1996–1997) multicenter surveillance study. Antimicrob Agents Chemother. 1999; 43: 357–9.
   Google Scholar
• Chardon H, Fosse T, Laurans G, et al. A 1-year study of antibiotic resistance among paediatric pneumococcal isolates in 1995 from four regions of France. Int J Antimicrob Agents. 1999, 13: 109–15.
   Google Scholar
• Song J-H, Yong Lee N, Ichiyama S, et al. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian network for surveillance of resistant pathogens (ANSORP) study. Clin Infect Dis. 1999; 28: 1206–11.
   Google Scholar
• Thornsberry C, Ogilvie P, Kahn J, Mauriz Y, and the laboratory investigator group. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory season. Diagn Microbiol Infect Dis. 1997; 29: 249–57.
   Google Scholar
• Koornhof HJ, Klugman KP. Evolution of extended spectrum cephalosporin resistance in the pneumococcus . J Antimicrob Chemother. 1997; 39: 837–42.
   Google Scholar
• Pikis A, Donkersloot JA, Akram S, Keith JM, Campos JM, Rodriguez WJ. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother. 1997; 40: 105–8.
   Google Scholar
• Doit C, Loukil C, Fitoussi F, Geslin P, Bingen E. Emergence in France of multiple clones of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin. Antimicrob Agents Chemother. 1999; 43: 1480–3.
   Google Scholar
• Butler DL, Gagnon RC, Miller LA, Poupard JA, Felmingham D, Griineberg RN. Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander project 1992–1996. J Antimicrob Chemother. 1999; 43: 777–82.
   Google Scholar
• Vanhoof, R. Comparative in-vitro activities of amoxycillin and penicillin against Streptococcus pneumoniae isolates. J Antimicrob Chemother. 1998; 42: 397–8.
   Google Scholar
• Fukuda H, Hiramatsu K. Primary targets of fluoroquinolones in Streptococcus pneumoniae. Antimicrob Agents Chemother. 1999; 43: 410–2.
   Google Scholar
• Varon E, Janoir C, Kitzis M-D, Gutmann L. ParC and GyrAmay be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniae. Antimicrob Agents Chemother. 1999; 43: 302–6.
   Google Scholar
• Broskey J, Coleman K, Gwynn MN et al. Efflux and target mutations as quinolone resistance mechanisms in clinical isolates of Streptococcus pneumoniae. J Antimicrob Chemother. 2000; 45, Suppl.S 1:95–9.
   Google Scholar
• Jones ME, Sahm DF, Martin N, et al. Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from worldwide surveillance studies during the 1997–1998 respiratory season. Antimicrob Agents Chemother. 2000; 44:462–6.
   Google Scholar
• Thornsberry C, Ogilvie PT, Holley, Jr. HP, Sahm DF. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents : a prospective U.S. Study. Antimicrob Agents Chemother. 1999; 43: 2612–23.
   Google Scholar
• Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med 1999; 341: 233–9.
   Google Scholar
• Verhaegen J, Verbist L. In-vitro activities of 16 non-β-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother. 1999; 43: 563–7.
   Google Scholar
• Heaton VJ, Goldsmith CE, Ambler JE, Fisher LM. Activity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae displaying topoisomerase- and effluxmediated resistance mechanisms. Antimicrob Agents Chemother. 1999; 43: 2998–3000.
   Google Scholar
• Yagupsky P, Porat N, Fraser D, et al. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in Southern Israel. J. Infect Dis. 1998; 177: 1003–12.
   Google Scholar